Edition:
United Kingdom

Rohto Pharmaceutical Co Ltd (4527.T)

4527.T on Tokyo Stock Exchange

2,872JPY
22 Nov 2017
Change (% chg)

¥-18 (-0.62%)
Prev Close
¥2,890
Open
¥2,935
Day's High
¥2,935
Day's Low
¥2,868
Volume
520,300
Avg. Vol
433,898
52-wk High
¥2,937
52-wk Low
¥1,607

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep 42,661.00 29.476
Jun 35,837.00 19.887
FY 2017 Mar '17 43,177.00 13.962
Dec 40,124.00 36.933
Sep 38,419.00 24.654
Jun 32,879.00 12.017
FY 2016 Mar '16 46,693.00 11.303
Dec 42,982.00 25.696
Sep 41,913.00 31.057
Jun 35,428.00 11.639
FY 2015 Mar '15 44,316.00 24.415
Dec 40,195.00 19.903
Sep 37,228.00 25.664
Jun 30,035.00 5.700
 
*Note: Units in Millions ofYen
**Note: Units in Yen

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-17 1 41,958.00 41,958.00 41,958.00 --
Quarter Ending Mar-18 1 43,930.00 43,930.00 43,930.00 --
Year Ending Mar-17 6 153,850.00 155,000.00 152,100.00 --
Year Ending Mar-18 6 163,700.00 167,500.00 159,200.00 165,767.00
Year Ending Mar-19 6 168,817.00 174,500.00 163,000.00 168,880.00
Earnings (per share)
Year Ending Mar-17 7 77.40 87.95 70.30 --
Year Ending Mar-18 7 97.84 105.34 89.60 86.65
Year Ending Mar-19 7 102.89 115.88 94.20 91.72
LT Growth Rate (%) 1 11.53 11.53 11.53 6.51
Sales and Profit Figures in Japanese Yen (JPY);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 26.83 31.15 32.96
P/E High - Last 5 Yrs. 25.72 40.78 45.57
P/E Low - Last 5 Yrs. 18.87 23.79 24.35
Beta 0.46 0.90 0.89
Price to Sales (TTM) 1.92 3.94 5.25
Price to Book (MRQ) 2.45 4.83 5.40
Price to Tangible Book (MRQ) 2.59 5.47 6.74
Price to Cash Flow (TTM) 18.03 23.18 23.58
% Owned Institutions -- 0.77 1.29

Dividends

  Company industry sector
Dividend Yield 0.82 1.54 1.48
Dividend Yield - 5 Year Avg 1.06 1.54 1.49
Dividend 5 Year Growth Rate 5.59 4.38 5.23
Payout Ratio(TTM) 21.92 45.05 43.12

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 9.00 3.32 8.84
Sales (TTM) vs TTM 1 Yr. Ago -4.20 4.75 5.41
Sales - 5 Yr. Growth Rate 5.15 10.23 10.45
EPS (MRQ) vs Qtr. 1 Yr. Ago 65.51 16.20 19.37
EPS (TTM) vs TTM 1 Yr. Ago 19.19 -- --
EPS - 5 Yr. Growth Rate 4.79 10.04 10.96
Capital Spending - 5 Yr. Growth Rate -14.44 15.37 15.32

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 1.44 2.12 2.20
Current Ratio (MRQ) 1.95 2.91 3.00
LT Debt to Equity (MRQ) 1.86 8.63 10.82
Total Debt to Equity (MRQ) 4.82 12.47 14.95
Interest Coverage (TTM) 53.12 37.12 33.97

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 59.00 54.92 54.68
Gross Margin - 5 Yr. Avg. 59.45 52.01 52.16
EBITD Margin (TTM) 14.28 -- --
EBITD - 5 Yr. Avg 14.21 18.41 15.51
Operating Margin (TTM) 9.19 14.62 9.27
Operating Margin - 5 Yr. Avg. 8.81 14.52 11.18
Pre-Tax Margin (TTM) 10.33 15.10 10.08
Pre-Tax Margin - 5 Yr. Avg. 9.52 14.85 11.61
Net Profit Margin (TTM) 6.93 11.35 6.37
Net Profit Margin - 5 Yr. Avg. 6.00 11.16 7.88
Effective Tax Rate (TTM) 32.85 23.30 23.20
Effective Tax Rate - 5 Yr. Avg. 36.96 23.46 24.03

Efficiency

  Company industry sector
Revenue/Employee (TTM) 23,746,350 967,481,648 876,729,110
Net Income/Employee (TTM) 1,646,722 113,847,927 103,151,977
Receivable Turnover (TTM) 4.07 5.62 5.78
Inventory Turnover (TTM) 2.53 2.58 3.35
Asset Turnover (TTM) 0.90 0.96 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 6.26 11.53 11.10
Return on Assets - 5 Yr. Avg. 5.40 13.15 12.57
Return on Investment (TTM) 8.82 14.99 14.58
Return on Investment - 5 Yr. Avg. 8.08 17.20 16.46
Return on Equity (TTM) 9.54 16.33 16.09
Return on Equity - 5 Yr. Avg. 8.72 18.16 17.62
  1 Year 3 Year 5 Year
Sales % -7.43 2.44 5.15
EPS (TTM) % 9.88 4.46 4.79
Dividend % 5.00 5.27 5.59
Note: Units in Millions of US Dollars

Performance for Rohto Pharmaceutical Co Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 1.43 -4.20 99 25
13 Week 12.82 7.46 99 36
26 Week 22.13 7.84 99 30
52 Week 45.18 16.51 99 12
YTD 39.34 25.42 99 23
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 37.60%
# of Holders: 93
Total Shares Held: 44,345,797
3 Mo. Net Change: -1,120,375
# New Positions: 2
# Closed Positions: 2
# Increased Positions: 20
# Reduced Positions: 18
# Net Buyers: 2
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.